Agios Pharmaceuticals AGIO Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Agios Pharmaceuticals's compensation and benefits?
- Agios Pharmaceuticals (AGIO) reported compensation and benefits of $11.69M in Q1 2026.
- How has Agios Pharmaceuticals's compensation and benefits changed year-over-year?
- Agios Pharmaceuticals's compensation and benefits increased by 49.8% year-over-year, from $7.8M to $11.69M.
- What is the long-term trend for Agios Pharmaceuticals's compensation and benefits?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's compensation and benefits has grown at a 6.0% compound annual growth rate (CAGR), from $20.35M to $27.26M.